Bacteremia Caused by Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae in Vientiane, Lao PDR: A 5-Year Study
Authors:
- Ko ChangKCKo Chang
- Sayaphet RattanavongSRSayaphet Rattanavong
- Mayfong MayxayMMMayfong Mayxay
- Valy KeoluangkhotVKValy Keoluangkhot
- Viengmon DavongVDViengmon Davong
- Manivanh VongsouvathMVManivanh Vongsouvath
- Manophab LuangrajMLManophab Luangraj
- Andrew J. H. SimpsonASAndrew J. H. Simpson
- Paul N. NewtonPNPaul N. Newton
- David A. B. DanceDavid A. B. Dance
Open Access
- 6 May 2020
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 102 (5) , 1137-1143
Abstract
Although there has been an increasing incidence of bacteremia caused by extended-spectrum beta-lactamase (ESBL)–producing Enterobacteriaceae (ESBL-E) across South East Asia, there are sparse data from the Lao PDR, where laboratory capacity for antimicrobial resistance surveillance is limited. We, therefore, retrospectively reviewed bacteremia caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae between 2010 and 2014 at Mahosot Hospital, Vientiane, Lao PDR. Clinical and laboratory data relating to all episodes of ESBL-E bacteremia were reviewed over the 5-year period and compared with non–ESBL-E bacteremia. Blood cultures positive for E. coli or K. pneumoniae were identified retrospectively from laboratory records. Clinical and laboratory data were extracted from research databases and case notes and analyzed using STATA. Between 2010 and 2014, we identified 360 patients with E. coli (n = 249) or K. pneumoniae (n = 111) bacteremia, representing 34.8% of all patients with clinically significant bacteremia. Seventy-two (20%) isolates produced ESBL; E. coli accounted for 15.3% (55/360) and K. pneumoniae for 4.7% (17/360), respectively. The incidence of ESBL-producing E. coli bacteremia rose during the study period. By multiple logistic analysis, reported antibiotic use in the previous week was significantly associated with ESBL positivity (P < 0.001, odds ratio 3.89). Although multiresistant, most ESBL-producing E. coli and K. pneumoniae remained susceptible to meropenem (65/65; 100%) and amikacin (64/65; 98.5%). We demonstrated an alarming increase in the incidence of ESBL-E as a cause of bacteremia in Vientiane during the study period. This has implications for empiric therapy of sepsis in Laos, and ongoing surveillance is essential.Keywords
This publication has 45 references indexed in Scilit:
- Bloodstream Infection among Adults in Phnom Penh, Cambodia: Key Pathogens and Resistance PatternsPLOS ONE, 2013
- Epidemiology, Microbiology and Mortality Associated with Community-Acquired Bacteremia in Northeast Thailand: A Multicenter Surveillance StudyPLOS ONE, 2013
- Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcomeAnnals of Hematology, 2012
- Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II studyInternational Journal of Antimicrobial Agents, 2012
- Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in EuropePLOS Medicine, 2011
- Characteristics of CTX-M ESBL-producing Escherichia coli isolates from the Lao People's Democratic Republic, 2004-09Journal of Antimicrobial Chemotherapy, 2011
- Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007Antimicrobial Agents and Chemotherapy, 2009
- Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coliClinical Microbiology and Infection, 2008
- Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial TreatmentAntimicrobial Agents and Chemotherapy, 2007
- Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2006